Algo version: 0.98b
Aclaris Therapeutics Inc is listed at the LSE Exchange
Aclaris Therapeutics Inc [0H8T.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is Aclaris Therapeutics Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Aclaris Therapeutics Inc 10 years ago, but if you had invested on Tuesday 22nd of December 2020 when the price was $7.07, you would have made a loss of $-3.16 per share or -44.70%

No, the average daily trading liquidity for Aclaris Therapeutics Inc is $12 279 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Aclaris Therapeutics Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Aclaris Therapeutics Inc to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.